Saavedra JM - Search Results

1

Increased expression of cardiac angiotensin II type 1 (AT(1)) receptors decreases myocardial microvessel density after experimental myocardial infarction.

de Boer RA, Pinto YM, Suurmeijer AJ, Pokharel S, Scholtens E, Humler M, Saavedra JM, Boomsma F, van Gilst WH, van Veldhuisen DJ. de Boer RA, et al. Among authors: saavedra jm. Cardiovasc Res. 2003 Feb;57(2):434-42. doi: 10.1016/s0008-6363(02)00704-6. Cardiovasc Res. 2003. PMID: 12566116

2

Beneficial effects of Angiotensin II receptor blockers in brain disorders.

Saavedra JM. Saavedra JM. Pharmacol Res. 2017 Nov;125(Pt A):91-103. doi: 10.1016/j.phrs.2017.06.017. Epub 2017 Jul 12. Pharmacol Res. 2017. PMID: 28711402 Review.

3

AT1 receptor blockade regulates the local angiotensin II system in cerebral microvessels from spontaneously hypertensive rats.

Zhou J, Pavel J, Macova M, Yu ZX, Imboden H, Ge L, Nishioku T, Dou J, Delgiacco E, Saavedra JM. Zhou J, et al. Among authors: saavedra jm. Stroke. 2006 May;37(5):1271-6. doi: 10.1161/01.STR.0000217404.64352.d7. Epub 2006 Apr 6. Stroke. 2006. PMID: 16601219

4

Mechanisms of the Anti-Ischemic Effect of Angiotensin II AT( 1 ) Receptor Antagonists in the Brain.

Saavedra JM, Benicky J, Zhou J. Saavedra JM, et al. Cell Mol Neurobiol. 2006 Oct-Nov;26(7-8):1099-111. doi: 10.1007/s10571-006-9009-0. Epub 2006 Apr 25. Cell Mol Neurobiol. 2006. PMID: 16636899 Review.

5

Expression and transport of Angiotensin II AT1 receptors in spinal cord, dorsal root ganglia and sciatic nerve of the rat.

Pavel J, Tang H, Brimijoin S, Moughamian A, Nishioku T, Benicky J, Saavedra JM. Pavel J, et al. Among authors: saavedra jm. Brain Res. 2008 Dec 30;1246:111-22. doi: 10.1016/j.brainres.2008.09.099. Epub 2008 Oct 17. Brain Res. 2008. PMID: 18976642 Free PMC article.

6

Angiotensin II type 1 receptors may not influence response of spinal autonomic neurons to axonal damage.

Tang H, Pavel J, Saavedra JM, Brimijoin S. Tang H, et al. Among authors: saavedra jm. Neurol Res. 2008 Sep;30(7):751-60. doi: 10.1179/174313208X298020. Epub 2008 May 21. Neurol Res. 2008. PMID: 18498681 Free PMC article.

7

A peripherally administered, centrally acting angiotensin II AT2 antagonist selectively increases brain AT1 receptors and decreases brain tyrosine hydroxylase transcription, pituitary vasopressin and ACTH.

Macova M, Pavel J, Saavedra JM. Macova M, et al. Among authors: saavedra jm. Brain Res. 2009 Jan 23;1250:130-40. doi: 10.1016/j.brainres.2008.11.006. Epub 2008 Nov 12. Brain Res. 2009. PMID: 19038235 Free PMC article.

8

Oral administration of an AT1 receptor antagonist prevents the central effects of angiotensin II in spontaneously hypertensive rats.

Seltzer A, Bregonzio C, Armando I, Baiardi G, Saavedra JM. Seltzer A, et al. Among authors: saavedra jm. Brain Res. 2004 Nov 26;1028(1):9-18. doi: 10.1016/j.brainres.2004.06.079. Brain Res. 2004. PMID: 15518636

9

Neuroprotective effects of angiotensin receptor blockers.

Villapol S, Saavedra JM. Villapol S, et al. Among authors: saavedra jm. Am J Hypertens. 2015 Mar;28(3):289-99. doi: 10.1093/ajh/hpu197. Epub 2014 Oct 31. Am J Hypertens. 2015. PMID: 25362113 Review.

10

Angiotensin receptor blockers for the treatment of COVID-19 and its comorbidities.

Saavedra JM. Saavedra JM. Pharmacol Res. 2020 Sep;159:104958. doi: 10.1016/j.phrs.2020.104958. Epub 2020 May 28. Pharmacol Res. 2020. PMID: 32473311 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

591 results

Search Page

Filters